Hoarding Symptoms Respond to Treatment for Rapid Cycling Bipolar II Disorder

2016 ◽  
Vol 22 (1) ◽  
pp. 50-55 ◽  
Author(s):  
LUANA D. LAURITO ◽  
LEONARDO F. FONTENELLE ◽  
DAVID A. KAHN
2005 ◽  
Vol 38 (5) ◽  
pp. 225-226 ◽  
Author(s):  
G. Valerius ◽  
N. C. Biedermann ◽  
L. O. Schaerer ◽  
J. M. Langosch

2017 ◽  
Vol 19 (1) ◽  
pp. 6-12
Author(s):  
Jay D Amsterdam ◽  
Lorenzo Lorenzo-Luaces ◽  
Robert J DeRubeis

2013 ◽  
Vol 202 (4) ◽  
pp. 301-306 ◽  
Author(s):  
Jay D. Amsterdam ◽  
Lola Luo ◽  
Justine Shults

BackgroundControversy exists over antidepressant use in rapid-cycling bipolar disorder.AimsExploratory analysis of safety and efficacy of fluoxetine v. lithium monotherapy in individuals with rapid- v. non-rapid-cycling bipolar II disorder.MethodRandomised, double-blind, placebo-controlled comparison of fluoxetine v. lithium monotherapy in patients initially stabilised on fluoxetine monotherapy (trial registration NCT0O044616).ResultsThe proportion of participants with depressive relapse was similar between the rapid- and non-rapid-cycling groups (P=0.20). The odds of relapse were similar between groups (P=0.36). The hazard of relapse was similar between groups (hazard ratio 0.87, 95% CI 0.40-1.91). Change in mania rating scores was similar between groups (P=0.86). There was no difference between groups in the rate of syndromal (P-0.27) or subsyndromal (P=0.82) hypomania.ConclusionsDepressive relapse and treatment-emergent mood conversion episode rates were similar for lithium and fluoxetine monotherapy and placebo during long-term, relapse-prevention therapy of rapid- and non-rapid-cycling bipolar II disorder.


2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Agius ◽  
G. Tavormina

Increasing understanding of the bipolar spectrum of disorders has led to an increasing integration of concepts regarding the aetiology and treatment of affective disorders.Thus, for example, we now understand that an illness, previously believed to be recurrent depressive disorder, may develop over time into a bipolar illness, and bipolar II illnesses may develop into bipolar I.Agitated depression may in fact be a mixed affective state, and injudicious use of powerful antidepressants in patients with undiagnosed bipolar disorder may lead to the development of mixed states or rapid cycling illness, as well as a complete switch from depression to mania.Mixed states and rapid cycling states are linked with increased suicidality.Meanwhile bipolar disorder, especially bipolar II disorder, remains a condition which is underdiagnosed and often inappropriately treated.Unfortunately, NICE guidelines are separate for Unipolar Depression and Bipolar Illness; those for Unipolar illness advocate a 'stepped care’ model, centred round primary care, while bipolar guidelines warn against injudicious use of antidepressants and the use of mood stabilisers to prevent ‘switching’ to mania.Primary care physicians are not warned to take a full longitudinal history in depressed patients, to identify bipolar illness, nor are they trained to use mood stabilisers in patients with bipolar II disorder, and in the risks of injudicious use of antidepressants.We need a single algorithm for identifying and treating affective disorders.The symposium will consider these issues as a prelude to a Europe Wide meeting planned for later in 2009, to develop guidelines about these issues.


2013 ◽  
Vol 202 (4) ◽  
pp. 251-252 ◽  
Author(s):  
Michael E. Thase

SummaryIt is suggested that a finding that apparently challenges current practice guidelines, namely that patients with a rapid-cycling pattern of bipolar disorder can take antidepressant monotherapy for months without increasing risk of cycling, may be parsimoniously understood by the way that the investigators defined rapid cycling and by their use of acute-phase fluoxetine monotherapy prior to randomisation to continutaion-phase therapy with fluoxetine, lithium or placebo.


Sign in / Sign up

Export Citation Format

Share Document